Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study
{{output}}
Background: The efficacy and tolerability of fremanezumab, a fully humanized monoclonal antibody (IgG2Δa) that selectively targets calcitonin gene-related peptide (CGRP) and is approved for the preventive treatment of migraine i... ...
